Clinical Research in the COVID-19 Era:

Methods for Continuity

The COVID-19 pandemic has led to a significant shift in day-to-day research operations. To keep research moving forward, sponsors need to build a solid foundation to support the virtualization of key components of clinical trials. In addition, the industry needs to maintain a participant-centric approach while ensuring participant safety and regulatory compliance throughout the trial.

Topics:

• The current state of clinical research
• Evolution of the traditional clinical trial model during the COVID-19 pandemic
• Best practices for moving to a virtual platform
• Tips for engaging with your IRB during the pandemic
• Regulatory considerations for moving to telemedicine and virtual trials